Markets move fast. You should move faster. Be the first to know when deals break, stocks move, or biotech headlines hit. Sign up to get breaking news alerts the moment they happen.
MongoDB stock surged after beating Q2 2026 earnings and raising forecasts. Record customer growth (5,000+ YTD), particularly from "AI-native companies," and strong Atlas revenue acceleration (29%) drove the success.
Eli Lilly's orforglipron showed positive results in its second Phase 3 obesity trial, achieving a weight loss of 9.6% at the highest dose. With a consistent safety profile, global regulatory submissions are imminent, aiming for 2026 approval.
Allarity's stenoparib gets FDA Fast Track for advanced ovarian cancer, aiming to expedite development for this serious condition and unmet medical need. A Phase 2 trial is enrolling patients, building on encouraging prior data.
AT&T acquires $23 billion in low-band and mid-band spectrum from EchoStar, significantly enhancing its 5G and home internet services across the U.S., driving long-term growth, and reinforcing its leadership in advanced connectivity.
Serina Therapeutics’ SER-252 for advanced Parkinson's gains FDA support for a registrational study via the 505(b)(2) NDA pathway. The POZ Platform enables continuous dopaminergic stimulation, aiming to improve motor fluctuations.
Aehr Test Systems secured orders for 6 Sonoma AI processor burn-in systems from a leading hyperscaler. These systems support custom AI ASICs for high-volume production, offering the lowest-cost, high-performance solution for the booming AI chip market.
